In line with our findings, quantitative hepatic steatosis in mice model of NASH using MCD diet was also unaffected by GLP-1 treatment [35], although GLP-1 treatment attenuated hepatic inflammation. Here, GCG is linked to metabolic dysfunction-associated steatohepatitis.